PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail tested for Tough-to-Treat brain cancer
Disease control CompletedThis early-phase trial tested whether combining three existing drugs (ibrutinib, rituximab, and lenalidomide) is safe and effective for adults whose lymphoma in the brain or spinal cord has returned or not responded to prior treatment. The main goal was to find the highest dose p…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 02:06 UTC
-
New drug tested to stop aggressive brain Cancer's return
Disease control CompletedThis study tested whether the drug nivolumab could safely prevent a type of aggressive brain lymphoma from growing back. It was for patients who had completed initial chemotherapy but still had signs of lingering cancer in their spinal fluid. The goal was to see if this maintenan…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC